Prosthetic Heart Valve Market, By Position Type, By Valve Type, By End User,, By Geography .

Description

The prosthetic heart valve market is estimated to be valued at USD 13.21 Bn in 2024 and is expected to reach USD 28.29 Bn by 2031, growing at a compound annual growth rate (CAGR) of 11.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 13.21 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	11.50%	2030/2031 Value Projection:	US$ 28.29 Bn

Prosthetic Heart Valve Market Share (%), By Region, 2024

The prosthetic heart valve market has been witnessing steady growth over the past few years owing to the increasing prevalence of heart valve diseases and rising number of valve replacement surgeries. Prosthetic heart valves help in replacing damaged heart valves that do not function properly. There has been a substantial increase in the patient pool suffering from heart valve conditions such as mitral and aortic regurgitation or stenosis due to aging population and risk factors like smoking, obesity, and diabetes. Moreover, technological advancements in valve design from mechanical valves to bioprosthetic valves and rising healthcare expenditure have been contributing towards the growth of the prosthetic heart valve market globally. However, high cost of treatment remains a key concern inhibiting wider adoption.

Market Dynamics:

Rising geriatric population base along with increasing burden of heart valve diseases across major countries act as the major growth drivers for the prosthetic heart valve market. As per estimates, over 16 million people suffer from valve diseases in the U.S. alone. The growing prevalence of obesity and diabetes which are major risk factors for developing valve defects supplement the market growth. Furthermore, introduction of technologically advanced, minimally invasive transcatheter heart valves as an alternative to conventional open-heart surgeries is gradually gaining adoption, bolstering the market revenues. However, prohibitively high costs associated with valve replacement surgeries limits widespread adoption, especially in developing regions. Stringent regulatory guidelines for new product approvals also impacts the market adversely. But ongoing R&D for developing affordable devices and enhanced technologies presents significant opportunities for prosthetic heart valve manufacturers over coming years.

Key Features of the Study:

This report provides an in-depth analysis of the global prosthetic heart valve market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global prosthetic heart valve market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes Edwards Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, CryoLife Inc., Braile Biomedica, Colibri Heart Valve LLC, JenaValve Technology , TTK Healthcare Limited , Lepu Medical Technology Co. Ltd , Foldax, Inc. , Symetis SA , On-X Life Technologies, and Braile Biomedica
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global prosthetic heart valve market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prosthetic heart valve market

Market Segmentation

Valve Type:
- Mechanical Valves
- Tissue Valves
- Transcatheter Valves
Position Type:
- Aortic Valve
- Mitral Valve
- Others
End User:
- Hospitals
- Ambulatory Surgical Centers
- Catheterization Laboratory
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Edwards Lifesciences Corporation
- Medtronic plc.
- Boston Scientific Corporation
- Abbott Laboratories
- LivaNova PLC
- CryoLife Inc.
- Braile Biomedica
- Colibri Heart Valve LLC
- JenaValve Technology Inc.
- TTK Healthcare Limited
- Lepu Medical Technology Co. Ltd
- Foldax, Inc.
- Symetis SA
- On-X Life Technologies
- Braile Biomedica

Product Code: CMI69

1. Research Objectives and Assumptions

Research Objectives
Assumptions

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Position Type
- Market Snapshot, By Valve Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancements
Merger, Acquisition and Collaboration Scenario
Recent Product Approvals
Identification of Key Players in Each Region
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis
Epidemiology
Healthcare Spending, by Country
Reimbursement Scenario
Distributors Landscape
Brand Mapping
Competitive Snapshot
Company Positioning Analysis
Heat Map Analysis

4. Global Prosthetic Heart Valve Market, By Position Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Aortic Valve, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Mitral Valve, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Prosthetic Heart Valve Market, By Valve Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Mechanical Valves, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Tissue Valves, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Transcatheter Valves, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Prosthetic Heart Valve Market, By End User, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Hospitals, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Ambulatory Surgical Centers, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Catheterization Laboratory, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Prosthetic Heart Valve Market, By Region, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2024 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest Of The Middle East
Africa
- Introduction
- Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa

8. Competitive Landscape

Competitive Snapshot
What Market Participants are Saying?
Competitive Dashboard
Company Market Share Analysis, 2024 - Global

9. Company Profiles - Global Prosthetic Heart Valve Market

Edwards Lifesciences Corporation*
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Medtronic plc.
Boston Scientific Corporation
Abbott Laboratories
LivaNova PLC
CryoLife Inc.
Braile Biomedica
Colibri Heart Valve LLC
JenaValve Technology Inc.
TTK Healthcare Limited
Lepu Medical Technology Co. Ltd
Foldax, Inc.
Symetis SA
On-X Life Technologies
Braile Biomedica

10. Wheel of Fortune

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact